Sugi Predict

Sugi Predict / Compounds / SCHEMBL7186834

SCHEMBL7186834

SCHEMBL7186834

Cc1cc(OC(C)C)ccc1PC(=O)c1c(C)cccc1C.[LiH]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.39
▸ TDP1 Q9NUW8 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ KMT2A Q03164 2/20 0.37
▸ RXRA P19793 1/20 0.37
▸ RXRB P28702 1/20 0.37
▸ PARP10 Q53GL7 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ GAA P10253 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ TSPO P30536 1/20 0.35
▸ PLA2G1B P04054 1/20 0.35
▸ ATG4B Q9Y4P1 1/20 0.35
▸ ACACB O00763 1/20 0.35
▸ ACACA Q13085 1/20 0.35
▸ MAPT P10636 1/20 0.34
▸ NPY1R P25929 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7177496 0.91 TYK2 (0.37) ALDH1A1TDP1POLBKMT2ARXRA
SCHEMBL7177670 0.89 ALDH1A1 (0.37) ALDH1A1TDP1POLBKMT2ARXRA
SCHEMBL7187692 0.89 ALDH1A1 (0.38) ALDH1A1TDP1POLBKMT2ARXRA
SCHEMBL7182015 0.89 FFAR4 (0.41) ALDH1A1TDP1POLBKMT2APARP10
SCHEMBL7175702 0.87 SMN1; SMN2 (0.38) ALDH1A1TDP1ACACBMAPTCXCR5
SCHEMBL7183348 0.87 CA12 (0.39) ALDH1A1TDP1HPGDGAAHTT
Lithium SCHEMBL7177679 0.86 ALDH1A1 (0.37) ALDH1A1TDP1POLBKMT2ARXRA
Lithium SCHEMBL7188424 0.86 TDP1 (0.36) ALDH1A1TDP1KMT2AGAAMEN1
SCHEMBL7180900 0.86 MEN1 (0.41) ALDH1A1TDP1KMT2AHPGDGAA
SCHEMBL7181543 0.85 NR1H4 (0.41) ALDH1A1TDP1POLBKMT2APARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 — — US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 — — US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 — — US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 ALDH1A1 3416/4885TDP1 4234/4885POLB 2322/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 ALDH1A1 3984/4885TDP1 4275/4885POLB 2993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.